TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Genscript Biotech ( (HK:1548) ) has shared an announcement.
Genscript Biotech Corporation announced that its associate, Legend Biotech Corporation, has released its financial results for the second quarter of 2025. The results, filed with the SEC, highlight Legend Biotech’s recent business achievements. Shareholders are advised to consider investment risks when dealing with Genscript’s securities.
More about Genscript Biotech
Genscript Biotech Corporation, incorporated in the Cayman Islands, operates in the biotech industry. The company is involved in the development and commercialization of innovative biotechnological products and services, with a focus on advancing healthcare solutions globally.
YTD Price Performance: 72.26%
Average Trading Volume: 29,301,189
Technical Sentiment Signal: Buy
Current Market Cap: HK$36.78B
For a thorough assessment of 1548 stock, go to TipRanks’ Stock Analysis page.